EUVIMED · CrossrefZeitschrift
Ophthalmology and Therapy
ISSN 2193-8245 · Springer Science and Business Media LLC
Neueste Artikel
Visual Outcomes of Autologous RPE-Based Transplantation for Massive Submacular Hemorrhage in Neovascular AMD and PCV: A Systematic Review and Meta-Analysis
Stratified Analysis of IOL Constant Optimization and Refractive Prediction Accuracy According to Ocular Biometric Parameters: Comparison with Overall Optimization
Visual and Patient-Reported Outcomes Following Supplemental Intraocular Lens Implantation for Pseudophakic Refractive Error in Eyes with Complex Ocular Comorbidities
Long-Term Anatomical Response to Navigated Micropulse Laser in Chronic Central Serous Chorioretinopathy: A 24-Month Longitudinal Study
Correction: STudy of Atropine to Reduce (STAR) Myopia Progression in Children: 24-Month Results of a Randomized, Double-Masked, Vehicle-Controlled Trial of Atropine Sulfate 0.01% and 0.03%
Polihexanide 0.8 mg/mL to Manage Acanthamoeba Keratitis in Clinical Practice: A Multicentre, Retrospective Study in Poland
Real-World Outcomes with Aflibercept 8 mg in Patients with Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME) – Retrospective Single-Center Data Analysis
Post Hoc MRI Analysis of Orbital Soft Tissue Volumes Pre- and Post-Teprotumumab in Patients with Chronic, Low-Activity Thyroid Eye Disease
Twelve-Month Visual, Refractive, and Ocular Wavefront Outcomes of SmartSight KLEx, Pooling Original and NOVA Workflows, on the SCHWIND ATOS: A Single-Surgeon Cohort Study
Wnt Pathway Agonism as a Therapeutic Strategy for Retinal Vascular Diseases: A Narrative Review of Evidence to Date
The Science and Clinical Evolution of Corneal Cross-Linking: Mechanism of Action, Ultra-Structural Changes, Clinical Indications, and Emerging Treatment Strategies
Prospective Real-World Outcomes After Switching to Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden
Functional Real-World Outcomes of Aflibercept 8 mg Versus Faricimab After Loading Phase in Diabetic Macular Edema
Summary of Research: Economic Benefit of Aflibercept 8 mg Versus Faricimab for Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the US
Long-Term Evolution of Treatment Outcomes with Once-Daily Ciclosporin A 0.1% Cationic Emulsion in Patients with Dry Eye Disease and Severe Keratitis
STudy of Atropine to Reduce (STAR) Myopia Progression in Children: 24-Month Results of a Randomized, Double-Masked, Vehicle-Controlled Trial of Atropine Sulfate 0.01% and 0.03%
Phase 3 Randomized Clinical Trial Evaluating the Safety of Reproxalap in Patients With Dry Eye Disease
Influence of Ocular Biometric Parameters on IOL Power Calculation Accuracy in Short and Normal Axial Length Eyes
One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report
Artificial Intelligence in Vitreoretinal Surgery: A Systematic Review of Current Applications and Future Directions
Immunomodulation of the Ocular Surface in Severe Dry Eye Disease: Expert-Driven Literature Review on Treatment Strategies with Description of Representative Challenging Cases
One-Year Real-World Outcomes of Aflibercept 8 mg in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report
Smartphone-Based Portable Slit Lamp in Anterior Segment Diseases: A Narrative Review of Clinical Assessment and Integration with Artificial Intelligence
The Light–Eye–Brain Axis: Neurobiological Links Between Mood Disorders and Myopia—A Narrative Review
Automated Report Generation in Ophthalmology: Integrating Artificial Intelligence, Multimodal Imaging, and Clinical Data
The Burden of Delayed Diabetic Retinopathy Management and Use of Artificial Intelligence-Driven Screening Tools: A Systematic Literature Review
Artificial Intelligence-Based Medical Devices for Diabetic Retinopathy Screening in the European Union
Patient and Physician Perspectives on the Management of Diabetic Macular Edema
Prediction Models for Recurrence of Retinopathy of Prematurity after Intravitreal Ranibizumab or Laser Photocoagulation Treatment: A Multicenter Cohort Study
Current Landscape and Future Prospects of Corneal Regenerative Medicine
EUVIMED